---
schema_version: "secwatch.filing_event.v1"
accession: "0001787306-25-000147"
form_type: "8-K"
ticker: "ARQT"
cik: "0001787306"
company_name: "Arcutis Biotherapeutics, Inc."
filed_at: "2025-12-08T23:59:59+00:00"
generated_at: "2026-05-16T14:01:54.192233+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Arcutis appoints Amit Munshi to Board; founder Chaudhuri retires, retains consulting role

## Summary
- Bhaskar Chaudhuri retired from Board and Compensation Committee chair on Dec 3, 2025; no disagreement.
- Chaudhuri entered consulting agreement through June 30, 2027 with hourly rate; options continue to vest.
- Amit Munshi appointed Class II director and Compensation Committee chair effective Dec 4, 2025.
- Munshi received initial option for 16,502 shares; eligible for prorated annual equity of ~$300,000 and cash retainers of $50,000 (Board) + $15,000 (chair).
- Munshi previously served as CEO of Arena Pharmaceuticals (acquired by Pfizer for $6.7B) and Orna Therapeutics.

## SEC filing metadata
- accession: 0001787306-25-000147
- form_type: 8-K
- ticker: ARQT
- cik: 0001787306
- company_name: Arcutis Biotherapeutics, Inc.
- filed_at: 2025-12-08T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1787306/000178730625000147/0001787306-25-000147-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1787306/000178730625000147/arqt-20251203.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001787306-25-000147
- JSON: https://secwatch.observer/filing/0001787306-25-000147.json
- Plain text: https://secwatch.observer/filing/0001787306-25-000147.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.